2/27/2008
An authorization from the FDA under section 564 of Reference (d) with respect to an unapproved product that allows, based on a declaration of emergency by the Secretary of Health and Human Services, the product to be introduced into interstate commerce for use or for the intended use, subject to terms and conditions established by the FDA. An EUA for an unapproved product exempts the product, within the terms of the EUA, from requirements applicable to investigational new drug.
DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101
The appearance of hyperlinks does not constitute endorsement by the Defense Health Agency of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.